The TSH upper reference limit: Where are we at?

Nature Reviews Endocrinology

Volumn 7, Issue 4, 2011, Pages 232-239

  Laurberg, Peter ^a   Andersen, Stig ^a   Carlé, Allan ^a   Karmisholt, Jesper ^a   Knudsen, Nils ^b   Pedersen, Inge Bülow ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLUCOCORTICOID; IODINE; LEVOTHYROXINE; THYROTROPIN;

AGE; CIRCADIAN RHYTHM; DIET RESTRICTION; DISEASE SEVERITY; ELDERLY CARE; GENETIC POLYMORPHISM; GLYCOSYLATION; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; MINERAL INTAKE; NONHUMAN; OBESITY; OVERNUTRITION; PREGNANCY; PRIORITY JOURNAL; RACE; REFERENCE VALUE; REVIEW; SEX; SLEEP; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; WEIGHT CHANGE;

FEMALE; HUMANS; HYPOTHYROIDISM; MALE; REFERENCE STANDARDS; THYROTROPIN;

EID: 79953111833     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2011.13     Document Type: Review

References (107)

1. Carlé, A. et al. Epidemiology of subtypes of hypothyroidism in Denmark. Eur. J. Endocrinol. 154, 21-28 (2006). (Pubitemid 43250732)
2. th Annual Meeting of the European Thyroid Association [online], http://www.hotthyroidology.com/ downloads/ETA-Lisbon-Abstracts.pdf (2009).
3. Andersen, S. et al. More hypothyroidism and less hyperthyroidism with sufficient iodine nutrition compared to mild iodine deficiency\a comparative population-based study of older people. Maturitas 64, 126-131 (2009).
4. Biondi, B. & Cooper, D. S. The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 29, 76-131 (2008). (Pubitemid 351252748)
5. Jones, D. D., May, K. E. & Geraci, S. A. Subclinical thyroid disease. Am. J. Med. 123, 502-504 (2010).
6. Fatourechi, V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin. Proc. 84, 65-71 (2009).
7. Mitchell, A. L. & Pearce, S. H. How should we treat patients with low serum thyrotropin concentrations? Clin. Endocrinol. (Oxf.) 72, 292-296 (2010).
8. Goichot, B., Sapin, R. & Schlienger, J. L. Subclinical hyperthyroidism: considerations in defining the lower limit of the thyrotropin reference interval. Clin. Chem. 55, 420-424 (2009).
9. Karmisholt, J., Andersen, S. & Laurberg, P. Analytical goals for thyroid function tests when monitoring patients with untreated subclinical hypothyroidism. Scand. J. Clin. Lab. Invest. 70, 264-268 (2010).
10. Parle, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C. & Sheppard, M. C. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin. Endocrinol. (Oxf.) 34, 77-83 (1991).
11. Díez, J. J. & Iglesias, P Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J. Clin. Endocrinol. Metab. 89, 4890-4897 (2004). (Pubitemid 39391424)
12. Karmisholt, J. & Laurberg, P Serum TSH and serum thyroid peroxidase antibody fluctuate in parallel and high urinary iodine excretion predicts subsequent thyroid failure in a 1-year study of patients with untreated subclinical hypothyroidism. Eur. J. Endocrinol. 158, 209-215 (2008). (Pubitemid 351298538)
13. Baloch, Z. et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13, 3-126 (2003).
14. Spencer, C. A., Hollowell, J. G., Kazarosyan, M. & Braverman, L. E. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J. Clin. Endocrinol. Metab. 92, 4236-4240 (2007). (Pubitemid 350074737)
15. Surks, M. I. & Hollowell, J. G. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 92, 4575-4582 (2007). (Pubitemid 350223429)
16. Surks, M. I. & Boucai, L. Age-and race-based serum thyrotropin reference limits. J. Clin. Endocrinol. Metab. 95, 496-502 (2010).
17. Hollowell, J. G. et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489-499 (2002). (Pubitemid 34158210)
18. Szkudlinski, M. W., Fremont, V., Ronin, C. & Weintraub, B. D. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiolog. Rev. 82, 473-502 (2002). (Pubitemid 34654459)
19. Beck-Peccoz, P, Amr, S., Menezes-Ferreira, M. M., Faglia, G. & Weintraub, B. D. Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. N. Eng. J. Med. 312, 1085-1090 (1985). (Pubitemid 15121217)
20. Rawlins, M. L. & Roberts, W. L. Performance characteristics of six third-generation assays for thyroid-stimulating hormone. Clin. Chem. 50, 2338-2344 (2004). (Pubitemid 39552170)
21. Weeke, J. & Gundersen, H. J. Circadian and 30 minutes variations in serum TSH and thyroid hormones in normal subjects. Acta Endocrinol. (Copenh.) 89, 659-672 (1978). (Pubitemid 9062044)
22. Brabant, G. et al. Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J. Clin. Endocrinol. Metab. 70, 403-409 (1990).
23. Brabant, G. et al. Early adaptation of thyrotropin and thyroglobulin secretion to experimentally decreased iodine supply in man. Metabolism 41, 1093-1096 (1992).
24. Glinoer, D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr. Rev. 18, 404-433 (1997). (Pubitemid 27246883)
25. Glinoer, D. & Spencer, C. A. Serum TSH determinations in pregnancy: how, when and why? Nat Rev. Endocrinol. 6, 526-529 (2010).
26. Hershman, J. M. The role of human chorionic gonadotropin as a thyroid stimulator in normal pregnancy. J. Clin. Endocrinol. Metab. 93, 3305-3306 (2008).
27. Glinoer, D. The importance of iodine nutrition during pregnancy. Public Health Nutr. 10, 1542-1546 (2007). (Pubitemid 350224310)
28. Soldin, O. P et al. Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency. Thyroid 14, 1084-1090 (2004). (Pubitemid 40076135)
29. Warner, M. H. & Beckett, G. J. Mechanisms behind the non-thyroidal illness syndrome: an update. J. Endocrinol. 205, 1-13 (2010).
30. Adler, S. M. & Wartofsky, L. The nonthyroidal llness syndrome. Endocrinol. Metab. Clin. North Am. 36, 657-672 (2007).
31. Boelen, A., Wiersinga, W. M. & Fliers, E. Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. Thyroid 18, 123-129 (2008). (Pubitemid 351271530)
32. Reinehr, T. Obesity and thyroid function. Mol. Cell. Endocrinol. 316, 165-171 (2010).
33. 43 understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab. 87, 1068-1072 (2002). (Pubitemid 36121067)
34. Hansen, P S. et al. Genetic and environmental interrelations between measurements of thyroid function in a healthy Danish twin population. Am. J. Physiol. Endocrinol. Metab. 292, E765-E770 (2007). (Pubitemid 46411054)
35. Dayan, C. M. & Panicker, V. Novel insights into thyroid hormones from the study of common genetic variation. Nat Rev. Endocrinol. 5, 211-218 (2009).
36. Harris, E. K. Effects of intra-and interindividual variation on the appropriate use of normal ranges. Clin. Chem. 20, 1535-1542 (1974).
37. Eisenberg, M. & Distefano, J. J. TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence. Thyroid 19, 103-110 (2009).
38. Vanderpump, M. P et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. (Oxf.) 43, 55-68 (1995).
39. Guan, H. et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin. Endocrinol. (Oxf.) 69, 136-141 (2008). (Pubitemid 351863590)
40. Walsh, J. P et al. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year longitudinal study of a community-based cohort using current immunoassay techniques. J. Clin. Endocrinol. Metab. 95, 1095-1104 (2010).
41. Stuckey, B. G., Kent, G. N., Ward, L. C., Brown, S. J. & Walsh, J. P Postpartum thyroid dysfunction and the long-term risk of hypothyroidism: results from a 12-year follow-up study of women with and without postpartum thyroid dysfunction. Clin. Endocrinol. (Oxf.) 73, 389-395 (2010).
42. Vejbjerg, P et al. The association between hypoechogenicity or irregular echo pattern at thyroid ultrasonography and thyroid function in the general population. Eur. J. Endocrinol. 155, 547-552 (2006). (Pubitemid 44608427)
43. Spencer, C. A. Contemporary issues in thyroid disease measurements. American Association for Clinical Chemistry [online], http://www.aacc.org/ events/expert access/2009/july/pages/default.aspx (2010).
44. Wartofsky, L. & Dickey, R. A. The evidence for a narrower thyrotropin reference range is compelling. J. Clin. Endocrinol. Metab. 90, 5483-5488 (2005). (Pubitemid 41262320)
45. Dickey, R. A., Wartofsky, L. & Feld, S. Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid 15, 1035-1039 (2005). (Pubitemid 41475713)
46. Surks, M. I., Goswami, G. & Daniels, G. H. The thyrotropin reference range should remain unchanged. J. Clin. Endocrinol. Metab. 90, 5489-5496 (2005). (Pubitemid 41262321)
47. Surks, M. I. et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291, 228-238 (2004). (Pubitemid 38082818)
48. Gharib, H. et al. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J. Clin. Endocrinol. Metab. 90, 581-585 (2005). (Pubitemid 40116712)
49. Meyerovitch, J. et al. Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch. Intern. Med. 167, 1533-1538 (2007). (Pubitemid 47124184)
50. Surks, M. I. & Hollowell, J. G. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 92, 4575-4582 (2007). (Pubitemid 350223429)
51. Boucai, L. & Surks, M. I. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin. Endocrinol. (Oxf.) 70, 788-793 (2009).
52. Atzmon, G., Barzilai, N., Hollowell, J. G., Surks, M. I. & Gabriely, I. Extreme longevity is associated with increased serum thyrotropin. J. Clin. Endocrinol. Metab. 94, 1251-1254 (2009).
53. Atzmon, G., Barzilai, N., Surks, M. I. & Gabriely, I. Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. J. Clin. Endocrinol. Metab. 94, 4768-4775 (2009).
54. Rozing, M. P et al. Familial longevity is associated with decreased thyroid function. J. Clin. Endocrinol. Metab. 95, 4979-4984 (2010).
55. Gussekloo, J. et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 292, 2591-2599 (2004). (Pubitemid 39577515)
56. Sathyapalan, T., Manuchehri, A. M., Rigby, A. S. & Atkin, S. L. Subclinical hypothyroidism is associated with reduced all-cause mortality in patients with type 2 diabetes. Diabetes Care 33, e37 (2010).
57. Utiger, R. D. Radioimmunoassay of human plasma thyrotropin. J. Clin. Invest 44, 1277-1286 (1965).
58. Laurberg, P et al. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur. J. Endocrinol. 155, 219-228 (2006). (Pubitemid 44269438)
59. Vejbjerg, P et al. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme. Clin. Endocrinol. (Oxf.) 71, 440-445 (2009).
60. Hamilton, T. E., Davis, S., Onstad, L. & Kopecky, K. J. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 93, 1224-1230 (2008). (Pubitemid 351519714)
61. Laurberg, P et al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract. Res. Clin. Endocrinol. Metab. 24, 13-27 (2010).
62. Duarte, G. C. et al. Excessive iodine intake and ultrasonographic thyroid abnormalities in schoolchildren. J. Pediatr. Endocrinol. Metab. 22, 327-334 (2009).
63. de Benoist, B., McLean, E., Andersson, M. & Rogers, L. Iodine deficiency in 2007: global progress since 2003. Food Nutr. Bull. 29, 195-202 (2008).
64. Sichieri, R. et al. Low prevalence of hypothyroidism among black and Mulatto people in a population-based study of Brazilian women. Clin. Endocrinol. (Oxf.) 66, 803-807 (2007). (Pubitemid 47024265)
65. Rasmussen, L. B. et al. Iodine intake before and after mandatory iodization in Denmark: results from the Danish Investigation of Iodine Intake and Thyroid Diseases (DanThyr) study. Br. J. Nutr. 100, 166-173 (2008).
66. Rodondi, N. et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality JAMA 304, 1365-1374 (2010).
67. Goichot, B., Sapin, R. & Schlienger, J. L. Subclinical hyperthyroidism: considerations in defining the lower limit of the thyrotropin reference interval. Clin. Chem. 55, 420-424 (2009).
68. Villar, H. C., Saconato, H., Valente, O. & Atallah, A. N. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst. Rev. 18, CD003419 (2007).
69. Razvi, S., Shakoor, A., Vanderpump, M., Weaver, J. U. & Pearce, S. H. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J. Clin. Endocrinol. Metab. 93, 2998-3007 (2008).
70. Cappola, A. R. et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295, 1033-1041 (2006).
71. Eskelinen, S. I. et al. Associations of thyroid-stimulating hormone and free thyroxine concentrations with health and life satisfaction in elderly adults. Endocr. Pract. 13, 451-457 (2007).
72. Bell, R. J. et al. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease\a community-based study. Clin. Endocrinol. (Oxf.) 66, 548-556 (2007). (Pubitemid 46434938)
73. Singh, S. et al. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int. J. Cardiol. 125, 41-48 (2008). (Pubitemid 351305426)
74. Ochs, N. et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med. 148, 832-845 (2008). (Pubitemid 351786932)
75. Simonsick, E. M. et al. Subclinical hypothyroidism and functional mobility in older adults. Arch. Intern. Med. 169, 2011-2017 (2009).
76. Haentjens, P, Van Meerhaeghe, A., Poppe, K. & Velkeniers, B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur. J. Endocrinol. 159, 329-341 (2008).
77. Razvi, S., Weaver, J. U., Vanderpump, M. P & Pearce, S. H. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J. Clin. Endocrinol. Metab. 95, 1734-1740 (2010).
78. Völzke, H. et al. Reference levels for serum thyroid function tests of diagnostic and prognostic significance. Horm. Metab. Res. 42, 809-814 (2010).
79. Laurberg, P, Andersen, S., Bülow Pedersen, I. & Carlé, A. Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment. Drugs Aging 22, 23-38 (2005). (Pubitemid 40188903)
80. Vanderpump, M. P How should we manage patients with mildly increased serum thyrotrophin concentrations? Clin. Endocrinol. (Oxf.) 72, 436-440 (2010).
81. Razvi, S., Weaver, J. U. & Pearce, S. H. Subclinical thyroid disorders: significance and clinical impact. J. Clin. Pathol. 63, 379-386 (2010).
82. Cooper, D. S. & Ridgway, E. C. Thoughts on prevention of thyroid disease in the United States. Thyroid 12, 925-929 (2002). (Pubitemid 35332998)
83. Somwaru, L. L., Arnold, A. M., Joshi, N., Fried, L. P & Cappola, A. R. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J. Clin. Endocrinol. Metab. 94, 1342-1345 (2009).
84. Hannemann, A. et al. Thyroid function tests in patients taking thyroid medication in Germany: Results from the population-based Study of Health in Pomerania (SHIP). BMC Res. Notes 3, 227 (2010).
85. Reid, S. M., Middleton, P, Cossich, M. C. & Crowther, C. A. Interventions for clinical and subclinical hypothyroidism in pregnancy Cochrane Database Syst. Rev. 7, CD007752 (2010).
86. Kuppens, S. M. et al. Maternal thyroid function during gestation is related to breech presentation at term. Clin. Endocrinol. (Oxf.) 72, 820-824 (2010).
87. Negro, R. et al. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J. Clin. Endocrinol. Metab. 95, E44-E48 (2010).
88. Cole, L. A. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod. Biol. Endocrinol. 7, 8 (2009).
89. Carlé, A. et al. Age modifies the pituitary TSH response to thyroid failure. Thyroid 17, 139-144 (2007). (Pubitemid 46365569)
90. Wiener, R., Utiger, R. D., Lew, R. & Emerson, C. H. Age, sex, and serum thyrotropin concentrations in primary hypothyroidism. Acta Endocrinol. (Copenh.) 124, 364-369 (1991).
91. Over, R., Mannan, S., Nsouli-Maktabi, H., Burman, K. D. & Jonklaas, J. Age and the thyrotropin response to hypothyroxinemia. J. Clin. Endocrinol. Metab. 95, 3675-3683 (2010).
92. Karmisholt, J., Andersen, S. & Laurberg, P. Interval between tests and thyroxine estimation method influence outcome of monitoring of subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 93, 1634-1640 (2008). (Pubitemid 351656498)
93. Rosário, P W., Bessa, B., Valadão, M. M. & Purisch, S. Natural history of mild subclinical hypothyroidism: prognostic value of ultrasound. Thyroid 19, 9-12 (2009).
94. Nyström, E. et al. Thyroid disease and high concentration of serum thyrotrophin in a population sample of women. A 4-year follow-up. Acta Med. Scand. 210, 39-46 (1981). (Pubitemid 11002640)
95. Tunbridge, W. M. et al. Natural history of autoimmune thyroiditis. Br. Med. J. (Clin. Res. Ed.) 282, 258-262 (1981). (Pubitemid 11188539)
96. Gray, R. S., Borsey, D. Q., Irvine, W. J., Seth, J. & Clarke, B. F. Natural history of thyroid function in diabetics with impaired thyroid reserve: a four year controlled study. Clin. Endocrinol. (Oxf.) 19, 445-451 (1983). (Pubitemid 13001505)
97. Rosenthal, M. J., Hunt, W. C., Garry, P J. & Goodwin, J. S. Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. JAMA 258, 209-213 (1987). (Pubitemid 17091239)
98. Kabadi, U. M. 'Subclinical hypothyroidism'. Natural course of the syndrome during a prolonged follow-up study. Arch. Intern. Med. 153, 957-961 (1993). (Pubitemid 23124736)
99. Huber, G. et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J. Clin. Endocrinol. Metab. 87, 3221-3226 (2002). (Pubitemid 34816369)
100. Karmisholt, J., Andersen, S. & Laurberg, P. Variation in thyroid function tests in patients with stable untreated subclinical hypothyroidism. Thyroid 18, 303-308 (2008). (Pubitemid 351415798)
101. Brabant, G. et al. Is there a need to redefine the upper normal limit of TSH? Eur. J. Endocrinol. 154, 633-637 (2006). (Pubitemid 43810847)
102. Okayasu, I., Hara, Y., Nakamura, K. & Rose, N. R. Racial and age-related differences in incidence and severity of focal autoimmune thyroiditis. Am. J. Clin. Pathol. 101, 698-702 (1994). (Pubitemid 24169300)
103. Okayasu, I. et al. Is focal chronic autoimmune thyroiditis an age-related disease? Differences in incidence and severity between Japanese and British. J. Pathol. 163, 257-264 (1991).
104. Li, M. et al. Endemic goitre in central China caused by excessive iodine intake. Lancet 2, 257-259 (1987).
105. Gärtner, R. in Comprehensive Handbook of Iodine: Nutritional, Biochemical, Pathological and Therapeutic Aspects Ch. 25 (eds Preedy, V R., Burrow, G. N. & Watson, R. W.) 243-247 (Elsevier Academic Press, Maryland Heights, 2009).
106. Vagenakis, A. G. & Braverman, L. E. Adverse effects of iodides on thyroid function. Med. Clin. North Am. 59, 1075-1088 (1975).
107. Li, Y. et al. Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes. J. Clin. Endocrinol. Metab. 93, 1751-1757 (2008). (Pubitemid 351656514)